INVO Fertility IVF
NASDAQ IVF
$1.18 +0.05 (+4.24%)
At close: Aug 20, 2026 · 1:23 PM UTC

INVO Fertility (IVF) Income from Discontinued Operations (2025)

INVO Fertility (IVF) posted quarterly Income from Discontinued Operations of 541247.0 for Q2 2025.

INVO Fertility (IVF) Income from Discontinued Operations (2025) Analysis & Trends

INVO Fertility (IVF) has reported Income from Discontinued Operations for 1 consecutive years, with 541247.0 the latest figure, recorded in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Abbott Laboratories 199.07 Bn 193.46 Bn 7.27 Bn -
2 Stryker 127.90 Bn 124.43 Bn 4.50 Bn -
3 Medtronic 118.84 Bn 109.62 Bn 6.41 Bn -
4 Boston Scientific 73.33 Bn 72.79 Bn 3.85 Bn -
5 Edwards Lifesciences 51.93 Bn 47.68 Bn 1.35 Bn -
6 Dexcom 34.46 Bn 32.51 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.91 Bn 31.81 Bn 2.18 Bn -
8 Koninklijke Philips 26.36 Bn 23.04 Bn 4.55 Bn -
9 Steris 23.12 Bn 22.64 Bn 684.20 Mn -
10 INVO Fertility 2.47 Mn 2.47 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 -541,247.00